Medicine
Dasatinib or High-dose Imatinib for Chronic-phase Chronic Myeloid Leukemia After Failure of First-line Imatinib: a Randomized Phase 2 Trial
J. Bajpai
Résumé
Le résumé n’est pas disponible.
Format de citation
BAJPAI, J. Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: A randomized phase 2 trial. Indian Journal of Medical and Paediatric Oncology, 2008, 29: 24.